Iodide

Iodide

SCHEMBL18824159

CC(C)n1c[n+](C(C)C)c2cc(OCCCCCCCCCCCO)ccc21.[I-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 1/20 0.38
▸ SRC P12931 1/20 0.38
▸ PDK2 Q15119 3/20 0.33
▸ ADRB2 P07550 1/20 0.33
▸ TP53 P04637 2/20 0.32
▸ GAA P10253 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CNR2 P34972 1/20 0.31
▸ PDE2A O00408 2/20 0.31
▸ ALDH2 P05091 3/20 0.31
▸ PNLIP P16233 3/20 0.31
▸ PDE3B Q13370 1/20 0.31
▸ PDE3A Q14432 1/20 0.31
▸ P2RY12 Q9H244 1/20 0.31
▸ MAOA P21397 2/20 0.30
▸ MAOB P27338 2/20 0.30
▸ SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18844463 0.99 FGFR1 (0.39) FGFR1SRCPDK2ADRB2TP53
Bicarbonate SCHEMBL18824162 0.92 FGFR1 (0.37) FGFR1SRCTP53MEN1NPC1
Bicarbonate SCHEMBL21046372 0.92 FGFR1 (0.35) FGFR1SRCGAAMEN1NPC1
Iodide SCHEMBL30731322 0.89 LTA4H (0.39) FGFR1TP53GAANPC1RAB9A
SCHEMBL17916653 0.88 LTA4H (0.40) FGFR1TP53GAANPC1RAB9A
SCHEMBL25860237 0.85 CARM1 (0.34) FGFR1ADRB2SIGMAR1
Iodide SCHEMBL21046358 0.85 CASR (0.35) ALDH2MAOAMAOB
SCHEMBL21046373 0.85 HTT (0.36) TP53GAAMEN1NPC1RAB9A
Bicarbonate SCHEMBL17911341 0.83 TP53 (0.39) TP53
Iodide SCHEMBL22366566 0.82 ADRB2 (0.33) ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11008291-B2 Methods of forming carbene-functionalized composite materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2021-05-18 — — US disclosed
US-20190169132-A1 Methods of Forming Carbene-Functionalized Composite Materials QUEEN'S UNIVERSITY AT KINGSTON (CA) 2019-06-06 — — US disclosed
WO-2017075704-A1 METHODS OF FORMING CARBENE-FUNCTIONALIZED COMPOSITE MATERIALS QUEEN'S UNIVERSITY AT KINGSTON (CA) 2017-05-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11008291-B2 Methods of forming carbene-functionalized composite materials VCL, CHN2, CA3 FGFR1 4725/4885SRC 2126/4885PDK2 1488/4885
US-20190169132-A1 Methods of Forming Carbene-Functionalized Composite Materials VCL, CHN2, CA3 FGFR1 4725/4885SRC 2126/4885PDK2 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback